Alphamab Oncology's KN046 Trial Misses Endpoint : vimarsana.

Alphamab Oncology (HK:9966) has released an update. Alphamab Oncology has announced that the Phase III clinical trial of KN046 for treating advance...

Related Keywords

, Alphamab Oncology ,